Sign in

Follicular lymphoma trials, also abroad

189 open Follicular lymphoma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States102
China52
Italy26
France25
Spain22
Germany19
Australia18
United Kingdom15
South Korea15
Poland14
Canada11
Türkiye9
Brazil8
Denmark8
Israel8
Japan8
Taiwan8
Greece6
Austria5
Belgium5
Czechia5
Finland5
Sweden5
Chile4
Argentina3
Switzerland3
India3
Moldova3
Netherlands3
Bulgaria2
Georgia2
Hong Kong2
Hungary2
Lithuania2
Puerto Rico2
Portugal2
Romania2
Thailand2
Ukraine2
United Arab Emirates1
Croatia1
Iceland1
Mexico1
Malaysia1
Russia1
Saudi Arabia1

The same trial often runs in several countries

Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7 has 4 sites in Norway and runs in 5 countries. If a site near you is full, another one may still take people.

See Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7 in all 5 countries